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Abstract The appearance of phosphatidylserine (PS) on the 
outer surface of apoptotic cells is an important signal for their 
ingestion. In platelets, elevation of intracellular Ca 2÷ with 
thapsigargin can trigger large amounts of PS exposure within 
minutes. We detected PS exposure in U937 promonocytes and 
J urkat T-cells after incubation with thapsigargin, but in only 
10% of the cells, and it took up to 6 h to occur. Tumor necrosis 
factor and anti-Fas antibody rapidly trigger apoptosis in these 
cells, and chelation of extracellular Ca 2+ with 5 mM EGTA 
inhibited PS exposure by 65% and 50%, respectively. Chelation 
of intracellular Ca 2+ with BAPTA-AM had no effect. Other 
parameters of apoptosis, including cell blebbing, shrinkage, 
nuclear fragmentation, activation of the ICE-like proteases, and 
fodrin cleavage, were not inhibited by extracelhilar EGTA. We 
conclude that while an elevation of intracellular Ca 2+ is an 
ineffective trigger of apoptosis in the cells investigated, extra- 
cellular Ca 2+ is required for efficient PS exposure during 
apoptosis. 
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~. Introduction 
Cells undergoing apoptosis are ingested by both neighbour- 
~ng cells and professional phagocytes. This prevents any in- 
itammation and tissue damage that could occur upon lysis of 
~he dying cell. One important mechanism for the recognition 
, ~f apoptotic ells is the expression of phosphatidylserine (PS) 
~n their outer surface [I]. PS is normally constrained to the 
nner leaflet of the plasma membrane [2], but disruption of 
,his asymmetry has been reported in a variety of cell types 
mdergoing apoptosis [3-9]. 
It has been known for many years that PS is exposed on the 
,,urface of activated platelets, where it plays an important role 
n the clotting cascade [10]. PS can also be exposed by red 
~lood cells and is involved in their clearance from circulation 
11]. Platelet activation causes rapid increase in intracellular 
2a 2+, and pharmacological modulation with Ca 2+ ionophores 
~r Ca2+-ATPase inhibitors can stimulate the exposure of large 
lmounts of PS by platelets within minutes [12]. Ca 2+ inacti- 
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vates the aminophospholipid translocase which normally con- 
strains PS to the inner leaflet [13], but this alone is insufficient 
for exposure. Another protein is proposed to mediate the 
scrambling of membrane phospholipids [14], although there 
is debate as to whether there is a general phospholipid scram- 
bling or a specific translocation of PS [15]. Reconstituted 
membranes have been used to study these mechanisms [16], 
and recently a 37 kDa protein has been extracted from red cell 
ghosts that can transport labelled phospholipids upon trigger- 
ing with Ca 2+ [] 7]. 
A variety of studies implicate Ca 2+ in the regulation of 
apoptosis [18]. Disruption of Ca 2+ homeostasis can trigger 
apoptosis [19], an increase in the concentration of intracellular 
Ca 2~ has been reported in some apoptotic models [20], and 
Ca 2+ chelators have been observed to block apoptosis [21]. In 
other models, changes in intracellular Ca 2+ are not so appar- 
ent, and Ca 2+ appears to inhibit apoptosis [22]. 
As elevation of intracellular Ca 2+ leads to rapid PS expo- 
sure in platelets, we tested the ability of thapsigargin, an in- 
hibitor of the endoplasmic reticulum Ca2+-ATPase [23], to 
initiate PS exposure in Jurkat T-cells and U937 promono- 
cytes. We also used chelators to investigate the involvement 
of Ca 2+ in PS exposure upon stimulation of apoptosis in these 
cells with anti-Fas antibody and TNF. 
2. Materials and methods 
2.1. Materials 
Jurkat and U937 cells were obtained from the Microbiology and 
Tumour Biology Centre, Karolinska Institutet. TNF was a generous 
gift from Dr. Grace Wong (Genentech Inc, San Francisco, CA). 
Thapsigargin was purchased from LC Laboratories (L/iufelfingen, 
Switzerland), anti-Fas IgM (CH-11) from Medical and Biological 
Laboratories (Nagoya, Japan), Z-VAD-cmk from Enzyme Systems 
Products (Dublin, CA), BAPTA-AM from Molecular Probes (Eu- 
gene, OR), anti-c~-fodrin monoclonal ntibody from Affiniti (Notting- 
ham, UK), and DEVD-AMC from Bachem (Bubendorf, Switzer- 
land). The Apoptest-FITC kit from Nexins Research B.V. (Hoeven, 
The Netherlands), containing annexin-FITC, was used for assaying 
PS exposure. All other chemicals were from Sigma (St. Louis, MO). 
2.2. Cell culture and preparation for experiments 
Cells were cultured in RPMI-1640 with 10% heat-inactivated foetal 
calf serum and 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml 
streptomycin. Cultures were incubated at 37°C in humidified air with 
5% carbon dioxide, and kept in logarithmic phase by routine passage 
every 2 3 days. Cells were centrifuged at 500×g for 5 rain before 
being resuspended in fresh medium at 106/ml. In some experiments, 
cells were resuspended in media with 5 mM EGTA (pH 7.4). Other 
cells were incubated with 10 [xM BAPTA-AM for 30 rain before being 
centrifuged and resuspended in fresh medium. Unless otherwise stat- 
ed, these procedures, plus addition of inhibitors, were all completed 
20 min before stimulation. Stimulation was with either 100 nM thap- 
sigargin, 12 ng/ml TNF with 1 ~tg/ml CHX, or 250 ng/ml anti-Fas 
antibody. 
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2.3. PS exposure 
PS exposure was measured by the binding of annexin V-FITC 
according to the protocol outlined by the manufacturers in the Apop- 
test-FITC kit. Cells were also stained with 100 Ixg/ml propidium io- 
dide, before being analysed with a Becton Dickinson FACScan flow 
cytometer with a 15 mW 488 nm argon laser. Ten thousand cells were 
counted, and those taking up propidium iodide were gated out of 
subsequent analysis. 
2.4. Cell blebbing and nuclear fragmentation 
The number of cells with large membrane protrusions was counted 
by light microscopy. Samples were also centrifuged at 1000×g for 
5 min and resuspended in 4% paraformaldehyde b fore being spread 
on slides coated with 3-aminopropyltriethoxysilane. Th  slides were 
rehydrated then stained with 10 ~tg/ml Hoechst 33342 for 10 min, 
rinsed in water, dried and sealed with Eukit and a coverslip. The 
fluorescent nuclei were viewed with a Leitz Diaplan fluorescent micro- 
scope. With both blebbing and nuclear fragmentation over 100 cells 
were assessed in two different fields of view. 
2.5. Protease activation 
The measurement of DEVD-AMC cleavage was modified from 
Nicholson et al. [26]. Lysates from 0.5 to 5× 106 cells were added 
to microtitre plates along with 100 mM HEPES, 10% sucrose, 5 mM 
dithiothreitol, and 0.1% CHAPS at pH 7.25. The reaction was started 
by the addition of 33 [xM DEVD AMC, whose cleavage to release 
free AMC was monitored at an excitation of 355 nm and emission of 
460 nm. Fluorescent units were converted to pmoles of AMC using a 
standard curve generated with free AMC. 
2.6. Fodrin cleavage 
Cells were pelleted and washed with ice-cold PBS (pH 7.1) contain- 
ing 100 ~tM phenylmethylsulfonyl fluoride (PMSF) before being re- 
suspended in sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% 
glycerol, 5% 2-mercaptoethanol, 100 ~tM PMSF) and boiled in a 
water bath for 5 min. Proteins were separated under reducing condi- 
tions at 120 V in 6% SDS-polyacrylamide g ls and then Western 
blotted at 100 V for 2 h. Blots were blocked overnight in a high 
salt buffer (HSB) (50 mM Tris-base, 500 mM NaCI, 0.05% Tween- 
20) containing 3% bovine serum albumin, and then incubated for 1 h 
with anti-c~-fodrin antibody diluted in HSB. After washing the blots 
4 times for 5 rain in HSB, they were incubated with a peroxidase- 
conjugated secondary antibody, and bound antibody was detected by 
enhanced chemiluminescence (Amersham). 
3. Results 
3.1. Induction of  PS  exposure with thapsigargin 
Cells were labelled with annexin-FITC and those expressing 
PS on their outer surface were assessed by flow cytometry [24]. 
Necrotic cells, detected by their uptake of propidium iodide, 
were gated out before analysis was undertaken. Fig. 1 is an 
example of the appearance of a population of viable PS-pos- 
itive U937 cells upon treatment with 100 nM thapsigargin. 
This exposure was both considerably slower and less than 
that reported with platelets. There was no detectable increase 
in PS exposure after 2 h (results not shown), but by 6 h 14% of 
the U937 and Jurkat cells expressed PS (Table 1). This corre- 
sponded to a 2.5-fold increase in the mean F ITC fluorescence 
of U937 cells and a 2-fold increase in the Jurkat cells (Table 1). 
During the flow cytometry analysis we also detected a small 
decrease in the forward scatter of the population (Table 1), 
indicative of the decrease in cell size that occurs during apop- 
tosis. Two other characteristic morphological features of 
apoptosis, membrane blebbing and nuclear fragmentation, 
were also observed upon treatment of cells with thapsigargin, 
but only occurred in approximately 10% of the cells (Table 1). 
One of the earliest changes observable in apoptotic cells is 
initiation of the interleukin-113 converting enzyme (ICE)-like 
proteolytic ascade [25]. A number of cysteine proteases with 
homology to ICE are activated and contribute to the cleavage 
of a variety of cellular substrates. One of these substrates, 
poly(ADP-ribose)polymerase (PARP), is cleaved at a specific 
Asp-Glu-Val  Asp (DEVD) sequence. This peptide has been 
linked to amino-4-methylcoumarin (AMC) to enable measure- 
ment of ICE-like protease activity in cell extracts, and the 
enzyme responsible for PARP cleavage was identified as 
CPP32/apopain [26,27]. After 6 h treatment with thapsigargin 
the level of DEVD AMC cleavage had increased to 3 times 
the control level in U937 cells and by nearly 4 times in the 
Jurkat cells (Table 1). As with PS exposure, there was no 
increase in activity after 2 h (results not shown). 
3.2. Mechanism of PS  exposure upon thapsigargin treatment 
EGTA was used to chelate extracellular Ca 2+. While EGTA 
does not affect the initial rise in intracellular Ca 2+ triggered by 
thapsigargin, it does prevent the maintenance of these levels 
by abolishing the capacitative influx of extracellular Ca 2+ [28]. 
Addition of 5 mM EGTA to the medium effectively inhibited 
PS exposure in both cell types, but did not inhibit DEVD-  
AMC cleavage in the cells (Table 2). This suggests that EGTA 
did not block stimulation by thapsigargin, although EGTA 
alone induced significant amounts of cleavage (Table 2). BAP- 
TA-AM is commonly used to chelate intracellular Ca 2+, but it 
induced large amounts of apoptosis in both cell types over the 
6 h period (results not shown). 
In many systems inactivation of the ICE-like proteases can 
block apoptosis. The cell-permeable peptide inhibitor Val-  
Ala-Asp-chloromethylketone (VAD-cmk) blocked Jurkat 
cell PS exposure upon treatment with thapsigargin (Table 
Table 1 
Induction of apoptosis by thapsigargin, TNF/CHX or anti-Fas antibody 
PS exposure FSC c Membrane blebbing d Nuclear frag. e DEVD-AMC 
% cells a mean fluor, b cleavagef 
U937 cells 
control 2.4_+ 0.2 32+ 4 338_+ 5 0 +0 2.0-+0.2 12 -+ 2 
+thapsigargin 14 -+ 2 80_+ 13 289+ 5 8.5+ 1.0 9.6-+0.4 37 -+ 4 
+TNF/CHX 49 _+ 12 126+44 179-+30 37 _+7 102 -+ 16 
Jurkat cells 
control 3.7_+0.7 43-+ 9 318+13 0 _+0 1.6-+0.6 5.9-+ 1.3 
+thapsigargin 14 _+4 92+22 291 -+ 13 8.1 -+ 1.6 9.2_+3.0 20 _+ 4 
+anti-Fas 43 _+8 147+29 227_+14 32 _+3 53 +15 
Cells were treated for 6 h with 100 nM thapsigargin, or for 2 h with either 12 ng/ml TNF and 1 ~tg/ml CHX, or 250 ng/ml anti-Fas antibody. 
Results are presented as the mean + SE of at least three experiments, aPercentage of cells appearing as PS positive, bMean annexin-FITC 
fluorescence of the viable population. CMean forward scatter of the viable population, d,ePercentages of the population showing membrane blebbing 
or nuclear fragmentation, fpmol of DEVD AMC cleaved per min per extract of 106 cells. 
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tig. 1. Induction of PS exposure in U937 cells by thapsigargin. Cells were treated with 100 nM thapsigargin for 6 h before being washed and 
stained with annexin FITC and propidium iodide. In each sample 10000 cells were analysed by flow cytometry. The fluorescence profiles of 
25% of the (A) unstimulated and (B) thapsigargin-treated c lls are shown from a representative experiment. 
2), indicating that disruption of Ca 2+ homeostasis led to PS 
e~posure via activation of the ICE-like proteolytic cascade. 
VAD-cmk was ineffective in the U937 system even though it 
t learly inhibited protease activity (Table 2). However, VAD- 
trek is known to be less effective in blocking TNF-mediated 
~poptosis in U937 cells ([9]; also see Table 3). 
. .3. Effect o f  EGTA on PS  exposure during TNF-  and 
Fas-mediated apoptosis 
Next we investigated two common models of receptor- 
laediated apoptosis: U937 cells stimulated with TNF  and 
( 'HX,  and Jurkat cells stimulated with anti-Fas antibody. In 
t ach model substantial apoptosis occurred within 2 h (Table 
). 
Fig. 2 plots PS exposure versus forward scatter. A decrease 
la forward scatter is indicative of the decrease in size that 
, ,ccurs as a cell shrinks and fragments into smaller bodies 
,',uring apotosis. TNF /CHX treatment resulted in a large pro- 
l,ortion of U937 cells with both decreased forward scatter and 
~ncreased PS exposure (Fig• 2B). Upon stimulating the cells in 
he presence of EGTA the cells still underwent a decrease in 
orward  scatter, but this population now expressed consider- 
.~bly less PS (Fig. 2C). The same effect was observed in Jurkat 
tells (Fig. 2E-G). In contrast, VAD-cmk prevented both the 
.... ize decrease and PS exposure in Jurkat cells (Fig. 2H). 
Exposure is normally quantitated by classifying a cell as 
~'ither PS-positive or PS-negative. We used the mean fluores- 
ence of the population to better estimate the shift in annexin 
qTC binding. Also, as EGTA increased the number of apop- 
otic cells (Table 3), and these cells have lower fluorescence 
)ecause of their smaller surface area, we focussed on the 
tpoptotic population. Analysis showed that EGTA inhibited 
~'S exposure by 65% in apoptotic U937 cells (Fig. 2A). EGTA 
~ad a lesser effect in the Jurkat cells, but still decreased PS 
~xposure by approximately 50% (Fig. 2B). EGTA did not 
nhibit any of the other apoptotic parameters, and in Jurkat 
,:ells in particular, actually increased the amount of apoptosis 
,)ccurring (Table 3). So too did BAPTA-AM, but unlike 
EGTA, it did not inhibit PS exposure. Therefore the inhibi- 
',ion by EGTA was specific to PS exposure and was due to the 
-emoval of extracellular Ca 2+ rather than disruption of intra- 
cellular levels. 
Before PS exposure was measured the cells were washed in 
fresh PBS with 1 mM Ca 2+, then resuspended with the F ITC-  
annexin in the presence of 1.8 mM Ca2+; therefore EGTA 
was not present o interfere in the annexin binding assay• To 
confirm this we added EGTA at the end of a 2 h stimulation, 
but before the washing procedure, and saw no effect on PS 
exposure (Figs• 2D and Fig. 3). Also, identical inhibition was 
observed when we used Ca2+-free RPMI  with 0.5 mM EGTA 
(to chelate the Ca 2÷ in the 10% serum) (Fig. 3). The inhibition 
of PS exposure in the presence of 5 mM EGTA was reversible 
as resuspension of cells into normal medium resulted in a 
return to optimal PS exposure within 30 min (Fig. 3A). 
The interaction of phospholipids with cytoskeletal proteins 
has been proposed to play a role in membrane asymmetry [2]. 
Cleavage of cytoskeletal c~-fodrin occurs during apoptosis 
[29]. Western blotting shows that the major band of a-fodrin 
is at 240 kDa in control cells and that activation of apoptosis 
generates 150 and 120 kDa cleavage products (Fig. 4). Fodrin 
cleavage also occurred in the presence of EGTA (Fig. 4), 
indicating that even if cleavage occurred, it was insufficient 
for PS exposure• 
Table 2 
Effect of EGTA and VAD-cmk on thapsigargin-mediated apoptosis 
PS exposure DEVD-AMC cleavage 
% of stimulated 
U937 cells and thaps 100 100 
+EGTA 7 _+ 20 t45 _+ 37 
EGTA alone -11 _+ 18 42_+ 17 
+VAD-cmk 80_+ 8 -26_+ 12 
VAD-cmk alone 8 + 2 --31 _+ 12 
Jurkat cells and thaps 100 100 
+EGTA 29-+ 11 191 + 32 
EGTA alone 40 + 25 89 -+ 26 
+VAD-cmk -8+ 0 -33_+ 0 
VAD-cmk alone -30+_ 0 -29_+ 0 
Cells were incubated for 20 min in medium with 5 mM EGTA (pH 
7.4) or with 10 p.M VAD-cmk, before being treated with 100 nM 
thapsigargin for 6 h. Results (mean + SE of 3 experiments) are pre- 
sented as a percentage of thapsigargin-stimulated c lls, after subtrac- 
tion of the values for unstimulated cells• 
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Fig. 2. PS exposure and forward scatter of TNF-treated U937 cells and anti-Fas-treated Jurkat cells• U937 cells (A-D) or Jurkat cells (E-H) 
were stimulated with TNF/CHX or anti-Fas, respectively, for 2 h before being stained with annexin-FITC and propidium iodide and analysed 
by flow cytometry. The forward scatter versus FITC fluorescence of 2500 propidium iodide-negative c lls are shown from a representative ex- 
periment. A,E: Control cells• B,F: Stimulated cells• C,G: Stimulated in the presence of 5 mM EGTA. D: Addition of EGTA after the 2 h 
stimulation• H: Stimulated in the presence of 10 TM VAD-cmk. 
4.  D iscuss ion  
We have shown that triggering of apoptosis in U937 and 
Jurkat cells in the absence of extracellular Ca 2+ leads to nor- 
mal membrane blebbing, cell shrinkage, activation of the ICE- 
like proteolytic ascade, and fodrin cleavage• The apoptotic 
cells, however, have considerably less PS present on the outer 
surface of their membrane• 
Platelets and red blood cells are the best studied models of 
PS exposure. In these systems an increase in intracellular Ca 2+ 
can rapidly trigger PS exposure. While thapsigargin induced 
PS exposure in U937 and Jurkat cells, it was considerably 
slower and weaker, and was inhibited by the protease inhibi- 
tor VAD-cmk. This suggests that PS exposure was the result 
of slow activation of the apoptotic program, rather than a 
direct effect on the enzyme(s) responsible for PS exposure• 
While the mechanism for translocation of PS to the outer 
surface may be identical between these cell types, it is appar- 
ent that platelets have a different activation pathway. This 
may reflect he necessity of a rapid platelet response for blood 
coagulation. 
The requirement for extracellular Ca 2+ in PS exposure was 
clear. Our data suggest hat the Ca 2+ was involved at a late 
stage of the pathway, possibly by the enzyme(s) that mediates 
the transfer of PS to the outer leaflet of the membrane. EGTA 
inhibited only PS exposure, while it actually enhanced the 
other apoptotic parameters measured. Also, readdition of 
Ca 2+ to apoptotic cells with impaired PS exposure resulted 
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[ig. 3. Effect of EGTA on PS exposure in apoptotic U937 and Jur- 
kat cells. (A) U937 or (B) Jurkat cells were stimulated with TNF/ 
( HX or anti-Fas for 2 h before being stained with annexin-FITC 
aad propidium iodide and analysed by flow cytometry. Results are 
calculated from the mean FITC fluorescence of the apoptotic popu- 
Ltion (those with decreased forward scatter), and expressed as a 
percentage of those stimulated in normal medium. Cells were tested 
i~ medium with 5 mM EGTA or Ca~+-free medium with 0.5 mM 
! GTA. After the 2 h stimulation some cell samples were centrifuged 
and resuspended in normal or 5 mM EGTA media. The mean and 
SE of at least 3 experiments are shown. 
in a rapid return to optimal exposure. This is what would be 
~~pected if all the necessary pathways had been activated by 
TNF  or anti-Fas, but that the enzyme(s) involved in transfer- 
ring the PS were lacking a crucial cofactor. The identity of 
these enzyme(s) is not yet clear. While it is known that Ca 2+ 
can trigger activation in platelets and red blood cells, it is not 
yet known if Ca 2+ is integral to activity when stimulated by 
an independent pathway. Confirmation of this will be depend- 
ent on further characterisation of the mechanics of PS ex- 
posure. 
The cleavage of fodrin has been suggested for initiation of 
PS exposure [29]. We found that even if fodrin cleavage occurs 
it does not necessarily lead to PS exposure. However, both 
fodrin cleavage and flippase activity may be necessary for PS 
exposure. The critical experiment would therefore be activa- 
tion of the flippase in the presence of intact fodrin. 
EGTA was used to chelate extracellular Ca 2+, but it also 
lowers intracellular levels by preventing the capacitative filling 
of depleted stores [30]. As such, it has been used to study the 
role of Ca 2+ in triggering the apoptotic program. Some see an 
inhibit ion of apoptosis with Ca 2+ chelators [21] and others an 
enhancement [22,31]. Results vary dramatically, depending on 
the cell type investigated. For example, our results with the 
Jurkat cells support those of Weis et al. [32] showing that Fas- 
mediated apoptosis is not affected by removal of Ca 2+, but 
Rovere et al. [33] showed that BAPTA inhibited apoptosis, 
including PS exposure, in a human 75 T-cell clone. 
A decrease in intracellular Ca 2+ by EGTA could have been 
responsible for the impairment of PS exposure that we de- 
tected. However, as elevating intracellular Ca 2+ with thapsi- 
gargin was an inefficient rigger of PS exposure in U937 and 
Jurkat cells, and the intracellular chelator BAPTA-AM did 
not prevent TNF-  and anti-Fas-mediated PS exposure, we 
believe that extracellular Ca 2+ is most likely to be involved. 
The small amount  of PS exposure that was stimulated with 
thapsigargin was also inhibited with EGTA,  supporting the 
TNF  and anti-Fas results. In this system EGTA did not ap- 
pear to block the thapsigargin signal, as ICE-like protease 
activation still occurred. As the thapsigargin-mediated in- 
crease in intracellular Ca 2+ is not sustained in the presence 
q able 3 
1 ffect of Ca 2+ chelators and VAD-cmk on TNF and Fas-mediated apoptosis 
PS exposure FSC Membrane blebbing DEVD cleavage 
% of stimulated 
i 1937 and TNF/CHX 100 100 100 100 
+ EGTA * 109 -+ 15 105 + 10 130 _+ 25 
EGTAalone -1_+10 2_+ 4 1_+ 1 3_+ 2 
+BAPTA-AM 138-+32 82+ 7 113+25 149-+22 
BAPTA-AM alone 20-+ 9 15-+ 6 7+ 6 14- + 9 
+VAD-cmk 87_+22 69+ 13 34-  + 5 -11 -+ 12 
VAD-cmk alone 4-+ 0 6_+ 0 0_+ 6 -37+34 
. urkat and Fas 100 100 100 100 
+EGTA * 174 -+ 30 188 -+ 12 174 -+ 29 
EGTA alone 19-+ 6 9-+ 5 2-+ 2 7 -  + 3 
+BAPTA-AM 256 _+ 34 152 + 43 259 +_ 30 266 + 56 
BAPTA-AM alone 24+ 11 24+ 17 12_+ 8 36_+ 9 
+VAD-cmk 11_+ 8 14_+ 8 7_+ 7 -11 + _ 5 
VAD-cmk alone -1+12 4_+ 0 0_+ 0 -12_+ 9 
~'ells were incubated for 20 min in medium with 5 mM EGTA (pH 7.4), with 10 laM VAD-cmk, or for 30 min with 10 gM BAPTA-AM before 
}~eing centrifuged and resuspended in fresh media. U937 cells were then treated for 2 h with 12 ng/ml TNF and 1 gg/ml CHX, and Jurkat cells were 
treated for 2 h with 250 ng/ml anti-Fas antibody. Results (mean + SE of at least 3 experiments) are presented as a percentage of stimulated cells, 
:~fter subtraction of the values for unstimulated cells. *The effect of EGTA on PS exposure is presented in Fig. 3. 
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I control 
II 
i 
! control 
I anti-Fas 
anti-Fas+EGTA 
I I EGTAanti'Fas+VAD 
t~ 
! I I 
Fig. 4. Effect of EGTA on fodrin cleavage in apoptotic Jurkat and 
U937 cells. U937 cells were treated with TNF (20 ng/ml) and CHX 
(1 gg/ml), and Jurkat cells were treated with anti-Fas (250 ng/ml) 
for 2 h. Some cell samples were pre-incubated with VAD-cmk (10 
gM) or EGTA (5 mM) for 20 min. The incubation was stopped by 
addition of cold PBS and the ~-fodrin content of lysed cells was 
analysed by Western blotting. The blot is from a representative ex- 
periment. 
of EGTA [28], it is possible that apoptosis was triggered by a 
slow depletion of endoplasmic reticulum Ca 2+ stores. The 
observed activation of apoptosis by EGTA or BAPTA-AM 
may also have occurred by the same mechanism. 
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